Fairscale Capital’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.2K Hold
25
0.01% 302
2026
Q1
$12K Hold
25
0.01% 305
2025
Q4
$14K Hold
25
0.01% 287
2025
Q3
$12.9K Hold
25
0.01% 311
2025
Q2
$10.7K Hold
25
0.01% 320
2025
Q1
$7.62K Hold
25
0.01% 259
2024
Q4
$8.31K Hold
25
0.01% 255
2024
Q3
$8.35K Hold
25
0.01% 257
2024
Q2
$11.4K Buy
+25
New +$9.9K 0.01% 252

Other funds holding MEDP

Fairscale Capital's MEDP Position: Q2 2026 in Review

Fairscale Capital held its Medpace (MEDP) position steady in Q2 2026 at 25 shares worth $13.2K. The position accounts for 0.01% of the portfolio, ranked #302.

Fairscale Capital first reported a position in MEDP in Q2 2024 and has held it in 9 quarters since. The position peaked at $14K in Q4 2025. 694 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Fairscale Capital held 25 shares of Medpace worth $13.2K as of Q2 2026.
  • Fairscale Capital left its Medpace share count unchanged in Q2 2026.
  • Medpace made up 0.01% of Fairscale Capital's portfolio in Q2 2026, its #302 holding.
  • Fairscale Capital first reported a position in Medpace in Q2 2024 and has held it in 9 quarters since.
  • Fairscale Capital's Medpace position peaked at $14K in Q4 2025.
  • 694 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Fairscale Capital's 13F filing for Q2 2026, filed 7 Aug 2026.